This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MediSwipe Inc. Announces MediSwipe DMS - Digital Patient Management And Tracking Software For Dispensaries, Provisional Centers And Caregivers Now Available To Register For Online Trial At Www.MediSwipe.com

LOS ANGELES, April 5, 2013 (GLOBE NEWSWIRE) -- MediSwipe Inc. ( www.MediSwipe.com ) ( MWIP), a patient security solutions and financial products company for the medicinal marijuana and health care industry, today announced that the Company's proprietary digital patient management and tracking software application developed for the medicinal marijuana sector "MediSwipe DMS", is now available to patients, caregivers and dispensaries to sign up and trial at www.MediSwipe.com . Those seeking to test the system must click on the banner and register to receive a log-in for the system. The MediSwipe DMS application includes patient registration, digital records management and tracking of all caregiver transactions including log-in time, date stamp and quantity and type of medication. Users under agreement will pay monthly licensing fees for access to the program.

"We are continuing our installation process of the MediSwipe DMS at the first five locations between Detroit and Ann Arbor, and are looking forward to releasing comments and feedback from operators once the system is in place over the next few weeks, giving them the opportunity to work with it and scan all patient files. We truly believe the MediSwipe DMS will prove to be the leading solution having the ability to track 'seed to sale', and allow us the opportunity to show legislators in every regulated state the immediate benefits of the MediSwipe DMS as a mandated solution for patient registration, tracking of medication and auditing of taxable state revenues," stated B. Michael Friedman, CEO for MediSwipe.

The company will also be appearing at the 42nd annual Hash Bash in Ann Arbor rally for marijuana reform on the University of Michigan Diag. This year's speakers include state Rep. Jeff Irwin, D-Ann Arbor, and Ann Arbor City Council Member Sabra Briere, D-1st Ward.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs